The Future Starts Now: What Healthcare Leaders Must Do Next

Persistent structural gaps threaten Mexico's healthcare system. These include insufficient resource allocation, specialist shortages, and uneven urban-rural access, alongside the growing burden of metabolic disease. However, new treatments and technologies could open the door to increasing access to healthcare services, says FunSalud.

Mexico's healthcare system continues to face structural spending gaps relative to other economies, said Hector Valle, President, FunSalud, during Mexico Health Summit 2026. He also urged healthcare leaders to act on long-standing structural weaknesses, from resource allocation to specialist shortages and uneven access between urban and rural areas.

During the event, Valle pointed to the rising burden of metabolic disease as a growing pressure point for the system, reinforcing the need for stronger prevention strategies across the sector. These challenges are not isolated obstacles but as interconnected pressures that will define the next phase of healthcare delivery in Mexico, he added. 

Closing spending and access gaps cannot happen through infrastructure investment alone, and that talent development, prevention strategy, and technology adoption must move in tandem for the system to keep pace with the country's evolving health needs, said Valle. This framing positions the coming years as a pivotal window for both public institutions and private industry to translate summit discussions into coordinated action. 

Looking ahead, Valle identifies GLP-1 therapies as one of the most consequential developments likely to reshape multiple industries, from pharmaceuticals and diagnostics to fitness and wellness. He says the companies best positioned to benefit will be those that combine a strong molecule, solid clinical evidence, broad patient access, and a well-designed patient experience.